What is HS-CRP / HDL Ratio?
The HS-CRP / HDL ratio is the relationship between high-sensitivity C-reactive protein (HS-CRP), an indicator of inflammation, and HDL, the “good” cholesterol that helps remove fat from the bloodstream. This ratio provides a snapshot of inflammation levels relative to cholesterol health.
Why does it matter for long-term health and wellbeing?
The HS-CRP / HDL ratio is a useful indicator of inflammation and heart health, with a lower ratio reflecting better balance between inflammation and cardiovascular health. Tracking this ratio helps optimise overall wellness, energy, and metabolism over time.
What's an optimal level of HS-CRP / HDL Ratio?
Optimal Range:
- HS-CRP: Less than 1 mg/L for low inflammation
- HDL: Above 1.0 mmol/L (an optimal ratio would show low CRP levels and high HDL, suggesting a healthier balance).
What influences HS-CRP / HDL levels?
Factors such as diet, physical activity, weight, and stress levels can impact these biomarkers. Regular exercise, a healthy diet, and stress management can support optimal levels.
What does it mean if HS-CRP / HDL is outside the optimal range?
A higher HS-CRP and a lower HDL may signal increased inflammation or suboptimal cardiovascular health, indicating areas where lifestyle improvements could be beneficial.
How can I support healthy HS-CRP / HDL levels?
To maintain healthy levels, focus on a balanced diet rich in antioxidants, omega-3 fatty acids, and healthy fats, regular physical activity, weight management, and stress reduction techniques like mindfulness or relaxation exercises.
References
- Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation. 2003. doi:10.1161/01.CIR.0000052939.59093.45. PMID: 12551878.
- Pathology Tests Explained. HDL cholesterol. https://ptex.au/ptests.php?q=HDL+cholesterol
- Gao Y, Wang M, Wang R, et al. The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study. Lipids in Health and Disease. 2024;23:66. doi:10.1186/s12944-024-02055-7.